West Breaks Ground on Facility in Ireland
PTSM: Pharmaceutical Technology Sourcing and Management
West Pharmaceutical began construction on its component manufacturing facility located in Waterford, Ireland.
West Pharmaceutical announced on June 16, 2015 that it broke ground on its Waterford, Ireland facility. The new pharmaceutical component manufacturing facility will focus on manufacturing “packaging components for insulin injector cartridges and other high-value packaging components for injectable drugs,” according to a press release.
"West's presence in Ireland is of great importance to us for meeting customer demand for high-quality packaging components. Packaging systems play an important role in ensuring the purity, long-term stability, and efficacy of injectable drug products. The advanced components that will be produced at our state-of-the-art Waterford plant will help our pharmaceutical and biotechnology customers deliver their products to patients," said Eric Green, CEO at West, in a press release.
The 95,000-square-foot-facility is expected to be opened in late 2018, and will employ approximately 150 engineers, production personnel, and other positions.
Source: West Pharmaceutical
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
